{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:02:05Z","timestamp":1789524125127,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007471","name":"Northern Borders University","doi-asserted-by":"publisher","award":["NBU-CRP-2016-2510"],"award-info":[{"award-number":["NBU-CRP-2016-2510"]}],"id":[{"id":"10.13039\/501100007471","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-05004-z","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:28:04Z","timestamp":1782743284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Silymarin-loaded phytosomal nanoparticles mitigate dyslipidemia, oxidative damage, and hepatic injury in high-fat diet-induced metabolic dysfunction-associated steatotic liver disease in rats"],"prefix":"10.1186","volume":"26","author":[{"given":"Shahad W.","family":"Kattan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany I.","family":"Almars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajnat A.","family":"Tounsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areej Ahmed","family":"Turkistani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona M.","family":"Elghareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekramy M.","family":"Elmorsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaymaa","family":"H.E. Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"3","key":"5004_CR1","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","volume":"69","author":"ZM Younossi","year":"2020","unstructured":"Younossi ZM, Stepanova M, Younossi Y, Golabi P, Mishra A, Rafiq N, Henry L. Epidemiology of chronic liver diseases in the USA in the past three decades. Gut. 2020;69(3):564\u20138.","journal-title":"Gut"},{"issue":"12","key":"5004_CR2","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41575-023-00822-y","volume":"20","author":"LA D\u00edaz","year":"2023","unstructured":"D\u00edaz LA, Arab JP, Louvet A, Bataller R, Arrese M. The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease. Nat Reviews Gastroenterol Hepatol. 2023;20(12):764\u201383.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"10","key":"5004_CR3","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184(10):2537\u201364.","journal-title":"Cell"},{"issue":"Suppl","key":"5004_CR4","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","volume":"29","author":"ML Teng","year":"2022","unstructured":"Teng ML, Ng CH, Huang DQ, Chan KE, Tan DJ, Lim WH, Yang JD, Tan E, Muthiah MD. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2022;29(Suppl):S32.","journal-title":"Clin Mol Hepatol"},{"issue":"7","key":"5004_CR5","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1053\/j.gastro.2022.01.058","volume":"162","author":"KC Bauer","year":"2022","unstructured":"Bauer KC, Littlejohn PT, Ayala V, Creus-Cuadros A, Finlay BB. Nonalcoholic fatty liver disease and the gut-liver axis: exploring an undernutrition perspective. Gastroenterology. 2022;162(7):1858\u201375. e1852.","journal-title":"Gastroenterology"},{"key":"5004_CR6","doi-asserted-by":"publisher","first-page":"106925","DOI":"10.1016\/j.phrs.2023.106925","volume":"196","author":"L Wang","year":"2023","unstructured":"Wang L, Yan Y, Wu L, Peng J. Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development. Pharmacol Res. 2023;196:106925.","journal-title":"Pharmacol Res"},{"key":"5004_CR7","doi-asserted-by":"crossref","unstructured":"Liu Y, Luo J, Peng L, Zhang Q, Rong X, Luo Y, Li J. Flavonoids: Potential therapeutic agents for cardiovascular disease. Heliyon 2024, 10(12).:e32563","DOI":"10.1016\/j.heliyon.2024.e32563"},{"issue":"3","key":"5004_CR8","first-page":"114","volume":"1","author":"SP Manavi","year":"2021","unstructured":"Manavi SP, Amiri T, Mozafaryan MJ. Role of flavonoids in diabetes. J Reviews Med Sci. 2021;1(3):114\u201326.","journal-title":"J Reviews Med Sci"},{"issue":"5","key":"5004_CR9","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1002\/fsn3.4010","volume":"12","author":"HM Jaffar","year":"2024","unstructured":"Jaffar HM, Al-Asmari F, Khan FA, Rahim MA, Zongo E. Silymarin: Unveiling its pharmacological spectrum and therapeutic potential in liver diseases\u2014A comprehensive narrative review. Food Sci Nutr. 2024;12(5):3097\u2013111.","journal-title":"Food Sci Nutr"},{"issue":"90","key":"5004_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.61186\/jmp.23.90.17","volume":"23","author":"B Roozbeh","year":"2024","unstructured":"Roozbeh B, Mehdipoor M, Rahimi GRM, Fathei M, Clifford T, Pourmirza B. Silymarin supplementation could improve the effect of exercise training on high-fat diet-induced metabolic disorders. J Med Plants. 2024;23(90):17\u201330.","journal-title":"J Med Plants"},{"issue":"4","key":"5004_CR11","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1002\/med.21791","volume":"41","author":"V Tvrd\u00fd","year":"2021","unstructured":"Tvrd\u00fd V, Pourov\u00e1 J, Jirkovsk\u00fd E, K\u0159en V, Valentov\u00e1 K, Mlad\u011bnka P. Systematic review of pharmacokinetics and potential pharmacokinetic interactions of flavonolignans from silymarin. Med Res Rev. 2021;41(4):2195\u2013246.","journal-title":"Med Res Rev"},{"key":"5004_CR12","doi-asserted-by":"publisher","first-page":"104378","DOI":"10.1016\/j.jddst.2023.104378","volume":"83","author":"M Macit","year":"2023","unstructured":"Macit M, Duman G, Cumbul A, Sumer E, Macit C. Formulation development of Silybum marianum seed extracts and silymarin nanoparticles, and evaluation of hepatoprotective effect. J Drug Deliv Sci Technol. 2023;83:104378.","journal-title":"J Drug Deliv Sci Technol"},{"key":"5004_CR13","unstructured":"Kalaivani P, Kamaraj R. Phytosome Technology: A Novel Breakthrough for the Health Challenges. Cureus 2024, 16(8):e68180"},{"issue":"8","key":"5004_CR14","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.3390\/ijms25084162","volume":"25","author":"L Toma","year":"2024","unstructured":"Toma L, Deleanu M, Sanda GM, Barb\u0103lat\u0103 T, Niculescu L\u015e, Sima AV, Stancu CS. Bioactive compounds formulated in phytosomes administered as complementary therapy for metabolic disorders. Int J Mol Sci. 2024;25(8):4162.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5004_CR15","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/jn\/133.4.1081","volume":"133","author":"SC Woods","year":"2003","unstructured":"Woods SC, Seeley RJ, Rushing PA, D\u2019Alessio D, Tso P. A controlled high-fat diet induces an obese syndrome in rats. J Nutr. 2003;133(4):1081\u20137.","journal-title":"J Nutr"},{"key":"5004_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jff.2019.03.012","volume":"56","author":"K-J Chang","year":"2019","unstructured":"Chang K-J, Lin J-A, Chen S-Y, Weng M-H, Yen G-C. Silymarin protects against high fat diet-evoked metabolic injury by induction of glucagon-like peptide 1 and sirtuin 1. J Funct Foods. 2019;56:136\u201344.","journal-title":"J Funct Foods"},{"issue":"2","key":"5004_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","volume":"10","author":"M Danaei","year":"2018","unstructured":"Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, Khorasani S. Mozafari yM: Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2):57.","journal-title":"Pharmaceutics"},{"key":"5004_CR18","unstructured":"Bancroft JD, Gamble M. Theory and practice of histological techniques. Elsevier health sciences; 2008."},{"issue":"3","key":"5004_CR19","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","volume":"53","author":"EM Brunt","year":"2011","unstructured":"Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA, Network NCR. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011;53(3):810\u201320.","journal-title":"Hepatology"},{"key":"5004_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.eswa.2019.03.049","volume":"130","author":"Y Huang","year":"2019","unstructured":"Huang Y, Chen Y, Zhu H, Li W, Ge Y, Huang X, He J. A liver fibrosis staging method using cross-contrast network. Expert Syst Appl. 2019;130:124\u201331.","journal-title":"Expert Syst Appl"},{"issue":"5","key":"5004_CR21","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/nu12051505","volume":"12","author":"JA Wali","year":"2020","unstructured":"Wali JA, Jarzebska N, Raubenheimer D, Simpson SJ, Rodionov RN, O\u2019Sullivan JF. Cardio-metabolic effects of high-fat diets and their underlying mechanisms\u2014a narrative review. Nutrients. 2020;12(5):1505.","journal-title":"Nutrients"},{"issue":"10","key":"5004_CR22","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3390\/nu9101072","volume":"9","author":"MA Van Herck","year":"2017","unstructured":"Van Herck MA, Vonghia L, Francque SM. Animal models of nonalcoholic fatty liver disease\u2014a starter\u2019s guide. Nutrients. 2017;9(10):1072.","journal-title":"Nutrients"},{"key":"5004_CR23","doi-asserted-by":"crossref","unstructured":"Rodrigues AA, Andrade RS, Vasconcelos DF. Relationship between experimental diet in rats and nonalcoholic hepatic disease: review of literature. Int J Hepatol 2018, 2018(1):9023027.","DOI":"10.1155\/2018\/9023027"},{"key":"5004_CR24","doi-asserted-by":"publisher","first-page":"105223","DOI":"10.1016\/j.compbiomed.2022.105223","volume":"142","author":"PS Dwivedi","year":"2022","unstructured":"Dwivedi PS, Patil VS, Khanal P, Bhandare VV, Gurav S, Harish DR, Patil B, Roy S. System biology-based investigation of Silymarin to trace hepatoprotective effect. Comput Biol Med. 2022;142:105223.","journal-title":"Comput Biol Med"},{"key":"5004_CR25","doi-asserted-by":"crossref","unstructured":"Yin S, Zhu F, Liu Y, Chen Q. Effects of silymarin on insulin resistance and sensitivity: A systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract 2025:112008.","DOI":"10.1016\/j.diabres.2025.112008"},{"issue":"2","key":"5004_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/iep.12008","volume":"94","author":"M Matsumoto","year":"2013","unstructured":"Matsumoto M, Hada N, Sakamaki Y, Uno A, Shiga T, Tanaka C, Ito T, Katsume A, Sudoh M. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. Int J Exp Pathol. 2013;94(2):93\u2013103.","journal-title":"Int J Exp Pathol"},{"issue":"1","key":"5004_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/jgh.16749","volume":"40","author":"XS Cui","year":"2025","unstructured":"Cui XS, Li HZ, Li L, Xie CZ, Gao JM, Chen YY, Zhang HY, Hao W, Fu JH, Guo H. Rodent model of metabolic dysfunction-associated fatty liver disease: a systematic review. J Gastroenterol Hepatol. 2025;40(1):48\u201366.","journal-title":"J Gastroenterol Hepatol"},{"key":"5004_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.colsurfb.2017.03.004","volume":"154","author":"J-S Lee","year":"2017","unstructured":"Lee J-S, Kim ES, Lee HG. Improving the water solubility and antimicrobial activity of silymarin by nanoencapsulation. Colloids Surf B. 2017;154:171\u20137.","journal-title":"Colloids Surf B"},{"issue":"4","key":"5004_CR29","first-page":"856","volume":"12","author":"M Akbari","year":"2025","unstructured":"Akbari M. Innovative drug delivery systems: nanotechnology in medicine. Int J New Chem. 2025;12(4):856\u201373.","journal-title":"Int J New Chem"},{"issue":"12","key":"5004_CR30","doi-asserted-by":"publisher","first-page":"E1472","DOI":"10.1152\/ajpendo.00102.2012","volume":"302","author":"H Poudyal","year":"2012","unstructured":"Poudyal H, Panchal SK, Ward LC, Waanders J, Brown L. Chronic high-carbohydrate, high-fat feeding in rats induces reversible metabolic, cardiovascular, and liver changes. Am J Physiology-Endocrinology Metabolism. 2012;302(12):E1472\u201382.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"key":"5004_CR31","unstructured":"Haddad Y. Antioxidant and hepatoprotective effects of silibinin in a rat model of nonalcoholic steatohepatitis. Evid Based Complement Alternat Med 2009, 1."},{"issue":"2","key":"5004_CR32","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jep.2010.01.004","volume":"128","author":"N Hamza","year":"2010","unstructured":"Hamza N, Berke B, Cheze C, Agli A-N, Robinson P, Gin H, Moore N. Prevention of type 2 diabetes induced by high fat diet in the C57BL\/6J mouse by two medicinal plants used in traditional treatment of diabetes in the east of Algeria. J Ethnopharmacol. 2010;128(2):513\u20138.","journal-title":"J Ethnopharmacol"},{"key":"5004_CR33","doi-asserted-by":"crossref","unstructured":"Abbasi E, Khodadadi I. High-fat diet may increase the risk of insulin resistance by inducing dysbiosis. Metabolism Open 2025:100381.","DOI":"10.1016\/j.metop.2025.100381"},{"key":"5004_CR34","doi-asserted-by":"publisher","first-page":"109860","DOI":"10.1016\/j.diabres.2022.109860","volume":"187","author":"Y Wen","year":"2022","unstructured":"Wen Y, Chen C, Kong X, Xia Z, Kong W, Si K, Han P, Liu WV, Li X. Pancreatic fat infiltration, \u03b2-cell function and insulin resistance: A study of the young patients with obesity. Diabetes Res Clin Pract. 2022;187:109860.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"5004_CR35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3892\/mmr.2020.11175","volume":"22","author":"S Jiang","year":"2020","unstructured":"Jiang S, Young JL, Wang K, Qian Y, Cai L. Diabetic-induced alterations in hepatic glucose and lipid metabolism: the role of type 1 and type 2 diabetes mellitus. Mol Med Rep. 2020;22(2):603\u201311.","journal-title":"Mol Med Rep"},{"issue":"1","key":"5004_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.5115\/acb.22.204","volume":"56","author":"RM Salama","year":"2023","unstructured":"Salama RM, Tayel SG. Silymarin attenuates escitalopram (cipralex) induced pancreatic injury in adult male albino rats: a biochemical, histological, and immunohistochemical approach. Anat cell biology. 2023;56(1):122\u201336.","journal-title":"Anat cell biology"},{"issue":"4","key":"5004_CR37","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.dld.2011.11.010","volume":"44","author":"F Salamone","year":"2012","unstructured":"Salamone F, Galvano F, Marino A, Paternostro C, Tibullo D, Bucchieri F, Mangiameli A, Parola M, Bugianesi E, Volti GL. Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis. Dig Liver Disease. 2012;44(4):334\u201342.","journal-title":"Dig Liver Disease"},{"issue":"12","key":"5004_CR38","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.3390\/ijms26125427","volume":"26","author":"D-I Gheonea","year":"2025","unstructured":"Gheonea D-I, Tocia C, Sacerdo\u021bianu V-M, Bocioag\u0103 A-G, Doica I-P, Manea NC, Turcu-\u0218tiolic\u0103 A, Oancea C-N, Dumitru E. Therapeutic Efficacy of Silymarin, Vitamin E, and Essential Phospholipid Combination Therapy on Hepatic Steatosis, Fibrosis, and Metabolic Parameters in MASLD Patients: A Prospective Clinical Study. Int J Mol Sci. 2025;26(12):5427.","journal-title":"Int J Mol Sci"},{"key":"5004_CR39","doi-asserted-by":"crossref","unstructured":"Elkanawati RY, Sumiwi SA, Levita J. Impact of lipids on insulin resistance: insights from human and animal studies. Drug Des Devel Ther 2024:3337\u201360.","DOI":"10.2147\/DDDT.S468147"},{"issue":"1","key":"5004_CR40","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12906-021-03275-5","volume":"21","author":"T Mengesha","year":"2021","unstructured":"Mengesha T, Gnanasekaran N, Mehare T. Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats. BMC Complement Med Ther. 2021;21(1):104.","journal-title":"BMC Complement Med Ther"},{"key":"5004_CR41","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.redox.2015.01.002","volume":"4","author":"H Sies","year":"2015","unstructured":"Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 2015;4:180\u20133.","journal-title":"Redox Biol"},{"key":"5004_CR42","doi-asserted-by":"crossref","unstructured":"Lau JKC, Zhang X, Yu J. Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances. J Pathol. 2017;241(1):36\u201344.","DOI":"10.1002\/path.4829"},{"key":"5004_CR43","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.biopha.2018.03.140","volume":"102","author":"A Taleb","year":"2018","unstructured":"Taleb A, Ahmad KA, Ihsan AU, Qu J, Lin N, Hezam K, Koju N, Hui L, Qilong D. Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases. Biomed Pharmacother. 2018;102:689\u201398.","journal-title":"Biomed Pharmacother"},{"key":"5004_CR44","doi-asserted-by":"crossref","unstructured":"Roy K, Lyer U. Role of silymarin in the management of non-alcoholic fatty liver disease: Time to clear the mist. Bioactive Compounds in Health and Disease-Online ISSN: 2574\u2009\u2013\u20090334; Print ISSN: 2769\u2009\u2013\u20092426 2019, 2(5):126\u201333.","DOI":"10.31989\/bchd.v2i5.622"},{"key":"5004_CR45","doi-asserted-by":"crossref","unstructured":"Polyak P SJ, Morishima C, Lohmann V, Pal S, Lee DY, Liu Y, Graf TN, Oberlies NH. Identification of hepatoprotective flavonolignans from silymarin. Proc Natl Acad Sci. 2010;107(13):5995\u20139.","DOI":"10.1073\/pnas.0914009107"},{"issue":"March","key":"5004_CR46","first-page":"1055","volume":"86","author":"AM FATMA","year":"2018","unstructured":"FATMA AM, MAHMOUD HAM, HANAN HA, HASHEM G, MAHMOUD M, Hesham M. The beneficial effects of silymarin in treatment of experimentally induced non-alcoholic fatty liver disease in rats. Med J Cairo Univ. 2018;86(March):1055\u201364.","journal-title":"Med J Cairo Univ"},{"key":"5004_CR47","doi-asserted-by":"publisher","first-page":"105168","DOI":"10.1016\/j.antiviral.2021.105168","volume":"194","author":"AC Ferraz","year":"2021","unstructured":"Ferraz AC, Almeida LT, da Silva Caetano CC, da Silva Menegatto MB, Lima RLS, de Senna JPN, de Oliveira Cardoso JM, Perucci LO, Talvani A, de Lima WG. Hepatoprotective, antioxidant, anti-inflammatory, and antiviral activities of silymarin against mayaro virus infection. Antiviral Res. 2021;194:105168.","journal-title":"Antiviral Res"},{"issue":"3","key":"5004_CR48","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.gendis.2020.06.005","volume":"8","author":"MR Zinatizadeh","year":"2021","unstructured":"Zinatizadeh MR, Schock B, Chalbatani GM, Zarandi PK, Jalali SA, Miri SR. The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases. Genes Dis. 2021;8(3):287\u201397.","journal-title":"Genes Dis"},{"key":"5004_CR49","doi-asserted-by":"crossref","unstructured":"Zhao Y, Zhou Y, Gong T, Liu Z, Yang W, Xiong Y, Xiao D, Cifuentes A, Ib\u00e1\u00f1ez E, Lu W. The clinical anti-inflammatory effects and underlying mechanisms of silymarin. IScience 2024;27(11):152649.","DOI":"10.1016\/j.isci.2024.111109"},{"key":"5004_CR50","first-page":"219","volume-title":"Seminars in arthritis and rheumatism: 2021","author":"JE Pope","year":"2021","unstructured":"Pope JE, Choy EH. C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. Seminars in arthritis and rheumatism: 2021. Elsevier; 2021. p. 219\u201329."},{"issue":"1","key":"5004_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1756-3305-5-9","volume":"5","author":"NM El-Lakkany","year":"2012","unstructured":"El-Lakkany NM, Hammam OA, El-Maadawy WH, Badawy AA, Ain-Shoka AA, Ebeid FA. Anti-inflammatory\/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis. Parasites vectors. 2012;5(1):9.","journal-title":"Parasites vectors"},{"key":"5004_CR52","doi-asserted-by":"crossref","unstructured":"Sayin F, Buyukbas S, Basarali M, Alp H, Toy H, Ugurcu V. Effects of Silybum marianum extract on high-fat diet induced metabolic disorders in rats. Pol J food Nutr Sci 2016;66(1):43\u201349.","DOI":"10.1515\/pjfns-2015-0014"},{"issue":"24","key":"5004_CR53","doi-asserted-by":"publisher","first-page":"8001","DOI":"10.1007\/s00018-021-04004-4","volume":"78","author":"R Gupta","year":"2021","unstructured":"Gupta R, Ambasta RK, Kumar P. Autophagy and apoptosis cascade: which is more prominent in neuronal death? Cell Mol Life Sci. 2021;78(24):8001\u201347.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"5004_CR54","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-genet-102108-134850","volume":"43","author":"C Wang","year":"2009","unstructured":"Wang C, Youle RJ. The role of mitochondria in apoptosis. Annu Rev Genet. 2009;43(1):95\u2013118.","journal-title":"Annu Rev Genet"},{"issue":"6","key":"5004_CR55","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.etp.2010.04.009","volume":"63","author":"S Aghazadeh","year":"2011","unstructured":"Aghazadeh S, Amini R, Yazdanparast R, Ghaffari SH. Anti-apoptotic and anti-inflammatory effects of Silybum marianum in treatment of experimental steatohepatitis. Exp Toxicol Pathol. 2011;63(6):569\u201374.","journal-title":"Exp Toxicol Pathol"},{"issue":"41","key":"5004_CR56","doi-asserted-by":"publisher","first-page":"57997","DOI":"10.1007\/s11356-021-14722-8","volume":"28","author":"MA Abd Eldaim","year":"2021","unstructured":"Abd Eldaim MA, Barakat ER, Alkafafy M, Elaziz SAA. Antioxidant and anti-apoptotic prophylactic effect of silymarin against lead-induced hepatorenal toxicity in rats. Environ Sci Pollut Res. 2021;28(41):57997\u20138006.","journal-title":"Environ Sci Pollut Res"},{"key":"5004_CR57","doi-asserted-by":"publisher","first-page":"102158","DOI":"10.1016\/j.tice.2023.102158","volume":"83","author":"FM G\u00fcr","year":"2023","unstructured":"G\u00fcr FM, Bilgi\u00e7 S. Silymarin, an antioxidant flavonoid, protects the liver from the toxicity of the anticancer drug paclitaxel. Tissue Cell. 2023;83:102158.","journal-title":"Tissue Cell"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05004-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05004-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05004-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:04:14Z","timestamp":1789520654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-05004-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5004"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-05004-z","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for all procedures was obtained from the Mansoura University Animal Care and Use Committee (MU- ACUC-M.V.R.25.10.249). The study adhered to Directive 2010\/63\/EU and was conducted in accordance with the ARRIVE guidelines 2.0, ensuring the protection of animals used for scientific purposes.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"571"}}